FilingReader Intelligence

Jiudian Pharmaceutical announces share repurchase plan

February 19, 2025 at 05:07 PM UTCBy FilingReader AI

Hunan Jiudian Pharmaceutical (SZSE:300705) announced plans to repurchase company shares using its own funds and special loan funds, aiming to implement a future equity incentive plan. The repurchase will be conducted through centralized bidding, with a price not exceeding 24.98 yuan per share. The total repurchase amount is planned to be no less than 100 million yuan and no more than 150 million yuan. Based on these figures, the company expects to repurchase between 4.0032 million and 6.0048 million shares, representing 0.81% to 1.21% of the current total share capital. The repurchase period will be within 12 months from the date the board of directors approves the plan. The funds will come from the company's own capital and a special loan for share repurchase, and the loan will account for no more than 90% of the total repurchase amount.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Hunan Jiudian Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →